+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Conventional and Alternative Pain Treatment Market

  • PDF Icon

    Report

  • 173 Pages
  • November 2024
  • Region: Global
  • BCC Research
  • ID: 6025090
Description Jump to:
The Conventional and Alternative Pain Treatment Market was valued at USD 96.2 billion in 2024, and is projected to reach USD 144.2 billion by 2029, rising at a CAGR of 8.40%.

The devices segment, which held a 36.6% share of the overall market in 2023, is expected to grow at a CAGR of 6.7%. The growth rate of this segment is attributed to factors such as the robust use of transcutaneous electrical nerve stimulation (TENS), spine stimulators and other electric impulse devices in North America, Europe, Latin America, the Middle East and most of the developed countries within the Asia-Pacific and Africa. The growth of the conventional and alternative pain treatment market can also be attributed to the growing number of physical procedures being performed in clinics and rehabs. The rise in demand for new drugs, cannabis drugs and other alternative devices is likely to drive the market.

Report Scope

This report covers the conventional and alternative pain treatments used by patients with chronic or acute pain. It provides the current and future market potential of conventional and alternative pain treatments and includes a detailed analysis of the competitive environment. The report covers the drivers, restraints and opportunities in the market; surveys the prevalence of or incidence of chronic diseases; and highlights emerging technologies for alternative treatment procedures. It includes market projections for 2029 and provides the market shares of key players.

In this analysis, the conventional and alternative pain treatment market is segmented based on pain management type into pharmaceuticals/drug therapy and devices. The pharmaceuticals/drug therapy segment is further segmented into non-narcotic analgesics, medical cannabis, narcotic analgesics, antimigraine agents, central nervous system (CNS) treatments, anesthetics, and other classes of pharmaceutical drug therapy. The devices segment of the conventional and alternative pain treatment market is further segmented into spine stimulators, electrotherapy/muscle stimulation, and other devices. Based on application, the overall conventional and alternative pain treatment market is segmented into orthopedic and musculoskeletal pain, general and broad pain management, surgical pain management, migraine/headache pain, neuropathic pain, cancer pain, fibromyalgia pain, and other pain types.

The overall conventional and alternative pain treatment market has also been segmented by geography into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa (MEA). Each regional analysis covers the region's leading countries, namely, the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico and GCC countries. Market data is provided for 2023, which serves as the base year; estimates are given for 2024 and forecast values for 2029.

The report includes:

  • 48 data tables and 56 additional tables
  • Analysis of the global market for conventional and alternative pain treatments
  • Analyses of global market trends, with market revenue data from 2012-2023, estimates for 2024, and projected CAGRs through 2029
  • Estimate of the current market size and revenue prospects of the global market, along with a market share analysis by pain management type, application and region
  • Facts and figures pertaining to the market dynamics, technological advances, regulations, and the influence of macroeconomic factors
  • A Porter's Five Forces analysis, a global supply chain analysis and a SWOT analysis
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies
  • A look at recent patent grants
  • Analysis of the industry structure and competitive landscape, including company market shares, strategic alliances, M&A activity and venture funding outlook
  • Profiles of market leaders, including: Medtronic, Abbott, GSK, Pfizer Inc., and Johnson & Johnson

Table of Contents

Chapter 1 Executive Summary
  • Market Outlook
  • Scope of Report
  • Market Summary
Chapter 2 Market Overview of Types of Pain and Its Treatment
  • Introduction
  • The Perception of Pain
  • How Pain is Treated
  • Pain Management Techniques: Electrical Stimulation
  • Pain Management Procedures
  • Alternative Methods of Pain Management
  • Growing Trend in Cannabis Treatment for Pain
  • Treatment Using Alternatives for Chronic Pain
Chapter 3 Market Dynamics
  • Introduction
  • Market Drivers
  • Rise in the Aging Population
  • Increasing Integration of Artificial Intelligence in Medical Devices
  • Rising Incidence of Chronic Diseases
  • Growth of Public Health Programs That Address Chronic Pain
  • Improvement in the Non-Drug Techniques
  • Market Restraints
  • Failure in Medical Device Designs
  • Supply Chain Issues and Quality Concerns
  • Market Opportunities
  • Expanding Usage of Wearable Devices
  • Technological Development for Conventional and Alternative Pain Treatment
  • Future Trends and Possibilities
Chapter 4 Emerging Technologies and Developments
  • Introduction
  • Regenerative Medicine
  • Advantages of Regenerative Pain Management
  • Minuteman Procedure
  • Peripheral Nerve Stimulation (PNS)
  • VIA Disc Treatment
  • Other Technologies
  • Wearable Devices and Biofeedback
  • Virtual Reality (VR) Therapy
  • Artificial Intelligence (AI) in Pain Prediction
  • Pain Management Clinical Trials
  • Trends in Development of Conventional and Alternative Pain Treatment
Chapter 5 Market Segmentation Analysis
  • Segmentation Breakdown
  • Market Breakdown by Pain Management Type
  • Market Size and Forecast
  • Pharmaceuticals/Drug Therapy
  • Market Size and Forecast
  • Non-Narcotic Analgesics
  • Medical Cannabis
  • Narcotic Analgesics
  • Antimigraine Agents
  • Central Nervous System (CNS) Treatments
  • Anesthetics
  • Other Classes
  • Devices
  • Market Size and Forecast
  • Spine Stimulators
  • Electrotherapy/Muscle Stimulation
  • Other Devices
  • Market Breakdown by Application
  • Market Size and Forecast
  • Orthopedic and Musculoskeletal Pain
  • Market Size and Forecast
  • General and Broad Pain Management
  • Market Size and Forecast
  • Surgical Pain Management
  • Market Size and Forecast
  • Migraine/Headache
  • Market Size and Forecast
  • Neuropathic Pain
  • Market Size and Forecast
  • Cancer Pain
  • Market Size and Forecast
  • Fibromyalgia Pain
  • Market Size and Forecast
  • Other Pain Types
  • Market Size and Forecast
  • Geographical Breakdown
  • Market Analysis by Region
  • Market Size and Forecast
  • North America
  • Market Size and Forecast
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Market Size and Forecast
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Market Size and Forecast
  • China
  • Japan
  • India
  • Australia and New Zealand
  • Rest of Asia-Pacific
  • Latin America
  • Market Size and Forecast
  • Brazil
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
  • Market Size and Forecast
  • South Africa
  • GCC Countries
  • Rest of the Middle East & Africa
Chapter 6 Competitive Intelligence
  • Introduction
  • Global Analysis of the Market and Its Leading Players
  • Agreements, Collaborations and Partnerships
  • 2023 Device Approvals
Chapter 7 Sustainability
  • Importance of ESG in the Conventional and Alternative Pain Treatment Industry
  • ESG Practices in the Pain Treatment Medical Device Industry
  • Environmental Performance
  • Social Performance
  • Governance Performance
  • ESG Ranking
  • BCC Research Viewpoint
Chapter 8 Appendix
  • Research Methodology
  • References
  • Company Profiles
  • ABBOTT
  • ABBVIE INC.
  • AMGEN INC.
  • BAXTER
  • BAYER AG
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • BOSTON SCIENTIFIC CORP.
  • GSK PLC
  • JOHNSON & JOHNSON SERVICES INC.
  • LILLY
  • MEDTRONIC
  • MERCK & CO. INC.
  • NOVARTIS AG
  • PFIZER INC.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
List of Tables
Summary Table: Global Conventional and Alternative Pain Treatment Market, by Pain Management Type, Through 2029
Table 1: Most Common Long-Term Health Conditions in Australia, by Age Group, 2022
Table 2: Clinical Trials for Pain Management at UCSF, 2024
Table 3: Additional Clinical Trials for Pain Management, 2024
Table 4: Complementary and Alternative Medicines, by Types
Table 5: Global Conventional and Alternative Pain Treatment Market, by Pain Management Type, Through 2029
Table 6: Global Conventional and Alternative Pain Treatment Market for Pharmaceuticals/Drug Therapy, by Region, Through 2029
Table 7: Global Conventional and Alternative Pain Treatment Market for Pharmaceuticals/Drug Therapy, by Type, Through 2029
Table 8: List of NSAIDs
Table 9: Global Non-Narcotic Analgesics Market, by Region, Through 2029
Table 10: Global Medical Cannabis Market, by Region, Through 2029
Table 11: Global Narcotic Analgesics Market, by Region, Through 2029
Table 12: Global Antimigraine Agents Market, by Region, Through 2029
Table 13: Global CNS Treatments Market, by Region, Through 2029
Table 14: Global Anesthetics Market, by Region, Through 2029
Table 15: Global Other Classes Market of Pharmaceutical Drug Therapy, by Region, Through 2029
Table 16: Global Conventional and Alternative Pain Treatment Market for Devices, by Type, Through 2029
Table 17: Global Conventional and Alternative Pain Treatment Market for Devices, by Region, Through 2029
Table 18: Global Spine Stimulators Market, by Region, Through 2029
Table 19: Global Electrotherapy/Muscle Stimulation Market, by Region, Through 2029
Table 20: Global Other Devices Market, by Region, Through 2029
Table 21: Global Conventional and Alternative Pain Treatment Market, by Application, Through 2029
Table 22: Global Orthopedic and Musculoskeletal Pain Application Market, by Region, Through 2029
Table 23: Global General and Broad Pain Management Application Market, by Region, Through 2029
Table 24: Global Surgical Pain Management Application Market, by Region, Through 2029
Table 25: Global Migraine/Headache Application Market, by Region, Through 2029
Table 26: Global Neuropathic Pain Application Market, by Region, Through 2029
Table 27: Cancer Pain Medication
Table 28: Global Cancer Pain Application Market, by Region, Through 2029
Table 29: Global Fibromyalgia Pain Application Market, by Region, Through 2029
Table 30: Global Other Pain Applications Market, by Region, Through 2029
Table 31: Global Conventional and Alternative Pain Treatment Market, by Region, Through 2029
Table 32: North American Conventional and Alternative Pain Treatment Market, by Country, Through 2029
Table 33: European Conventional and Alternative Pain Treatment Market, by Country, Through 2029
Table 34: Chronic Pain Rates, by Population and Percentage Affected, 2029
Table 35: Asia-Pacific Conventional and Alternative Pain Treatment Market, by Country, Through 2029
Table 36: Latin American Countries that Participated in the FEDELAT survey, 2017-2022
Table 37: Latin American Conventional and Alternative Pain Treatment Market, by Country, Through 2029
Table 38: Middle Eastern & African Conventional and Alternative Pain Treatment Market, by Sub-Region, Through 2029
Table 39: Medical Devices Cleared or Approved by FDA, 2023
Table 40: ESG Practices: Environmental Performance
Table 41: ESG Practices: Social Performance
Table 42: ESG Practices: Governance Performance
Table 43: ESG Rankings for Major Medical Device Companies, 2023 and 2024*
Table 44: Abbott: Company Snapshot
Table 45: Abbott: Financial Performance, 2022 and 2023
Table 46: Abbott: Product Portfolio
Table 47: Abbott: News/Key Developments, 2022 and 2023
Table 48: AbbVie Inc.: Company Snapshot
Table 49: AbbVie Inc.: Financial Performance, 2022 and 2023
Table 50: AbbVie Inc.: Product Portfolio
Table 51: AbbVie Inc.: News/Key Developments, 2024
Table 52: Amgen Inc.: Company Snapshot
Table 53: Amgen Inc.: Financial Performance, 2022 and 2023
Table 54: Amgen Inc.: Product Portfolio
Table 55: Amgen Inc.: News/Key Developments, 2022 and 2023
Table 56: Baxter: Company Snapshot
Table 57: Baxter: Financial Performance, 2022 and 2023
Table 58: Baxter: Product Portfolio
Table 59: Baxter: News/Key Developments, 2021-2024
Table 60: Bayer AG: Company Snapshot
Table 61: Bayer AG: Financial Performance, 2022 and 2023
Table 62: Bayer AG: Product Portfolio
Table 63: Bayer AG: News/Key Developments, 2023
Table 64: Boehringer Ingelheim International GmbH: Company Snapshot
Table 65: Boehringer Ingelheim International GmbH: Financial Performance, 2022 and 2023
Table 66: Boehringer Ingelheim International GmbH: Product Portfolio
Table 67: Boehringer Ingelheim International GmbH: News/Key Developments, 2022-2024
Table 68: Boston Scientific Corp.: Company Snapshot
Table 69: Boston Scientific Corp.: Financial Performance, 2022 and 2023
Table 70: Boston Scientific Corp.: Product Portfolio
Table 71: Boston Scientific Corp.: News/Key Developments, 2023 and 2024
Table 72: GSK Plc: Company Snapshot
Table 73: GSK Plc: Financial Performance, 2022 and 2023
Table 74: GSK Plc: Products Portfolio
Table 75: GSK Plc.: News/Key Developments, 2021 and 2022
Table 76: Johnson and Johnson Services Inc.: Company Snapshot
Table 77: Johnson and Johnson Services Inc.: Financial Performance, 2022 and 2023
Table 78: Johnson and Johnson Services Inc.: Product Portfolio
Table 79: Johnson and Johnson Services Inc.: News/Key Developments, 2021-2024
Table 80: Lilly: Company Snapshot
Table 81: Lilly: Financial Performance, 2022 and 2023
Table 82: Lilly: Product Portfolio
Table 83: Lilly: News/Key Developments, 2021 and 2022
Table 84: Medtronic: Company Snapshot
Table 85: Medtronic: Financial Performance, 2022 and 2023
Table 86: Medtronic: Product Portfolio
Table 87: Medtronic: News/Key Developments, 2022-2024
Table 88: Merck & Co. Inc.: Company Snapshot
Table 89: Merck & Co. Inc.: Financial Performance, 2022 and 2023
Table 90: Merck & Co. Inc.: Product Portfolio
Table 91: Merck & Co. Inc.: News/Key Developments, 2022-2024
Table 92: Novartis AG: Company Snapshot
Table 93: Novartis AG: Financial Performance, 2022 and 2023
Table 94: Novartis AG: Product Portfolio
Table 95: Novartis AG: News/Key Developments, 2022 and 2023
Table 96: Pfizer Inc.: Company Snapshot
Table 97: Pfizer Inc.: Financial Performance, 2022 and 2023
Table 98: Pfizer Inc.: Product Portfolio
Table 99: Pfizer Inc.: News/Key Developments, 2021-2024
Table 100: Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 101: Teva Pharmaceutical Industries Ltd.: Financial Performance, 2022 and 2023
Table 102: Teva Pharmaceutical Industries Ltd.: Product Portfolio
Table 103: Teva Pharmaceutical Industries Ltd.: News/Key Developments, 2021-2024
List of Figures
Summary Figure: Global Conventional and Alternative Pain Treatment Market Shares, by Pain Management Type, 2023
Figure 1: Pain Management Treatments
Figure 2: Market Dynamics
Figure 3: Global Projected Shares of Elderly Population (Aged 65 Years and Older), by Region, 2050
Figure 4: Future Trends for Pain Management
Figure 5: Types of Pain Management Techniques and Their Usage
Figure 6: Most Popular Forms of Alternative Medicines and Therapies in the U.S., 2022
Figure 7: Global Conventional and Alternative Pain Treatment Market Shares, by Pain Management Type, 2023
Figure 8: Global Conventional and Alternative Pain Treatment Market Shares for Pharmaceuticals/Drug Therapy, by Type, 2023
Figure 9: Global Conventional and Alternative Pain Treatment Market Shares for Device, by Type, 2023
Figure 10: Global Conventional and Alternative Pain Treatment Market Shares, by Application, 2023
Figure 11: Projections of Osteoarthritis, 2050
Figure 12: Global Conventional and Alternative Pain Treatment Market Shares, by Region, 2023
Figure 13: North American Conventional and Alternative Pain Treatment Market Shares, by Pain Management Type, 2023
Figure 14: North American Conventional and Alternative Pain Treatment Market Shares for Pharmaceuticals/Drug Therapy, by Type, 2023
Figure 15: North American Conventional and Alternative Pain Treatment Market Shares for Devices, by Type, 2023
Figure 16: North American Conventional and Alternative Pain Treatment Market Shares, by Application, 2023
Figure 17: North American Conventional and Alternative Pain Treatment Market Shares, by Country, 2023
Figure 18: European Conventional and Alternative Pain Treatment Market Shares, by Pain Management Type, 2023
Figure 19: European Conventional and Alternative Pain Treatment Market Shares for Pharmaceuticals/Drug Therapy, by Type, 2023
Figure 20: European Conventional and Alternative Pain Treatment Market Shares for Devices, by Type, 2023
Figure 21: European Conventional and Alternative Pain Treatment Market Shares, by Application, 2023
Figure 22: European Conventional and Alternative Pain Treatment Market Shares, by Country, 2023
Figure 23: Spanish Spending Across All Healthcare Categories
Figure 24: Asia-Pacific Conventional and Alternative Pain Treatment Market Shares, by Pain Management Type, 2023
Figure 25: Asia-Pacific Conventional and Alternative Pain Treatment Market Shares for Pharmaceuticals/Drug Therapy, by Type, 2023
Figure 26: Asia-Pacific Conventional and Alternative Pain Treatment Market Shares for Devices, by Type, 2023
Figure 27: Asia-Pacific Conventional and Alternative Pain Treatment Market Shares, by Application, 2023
Figure 28: Asia-Pacific Conventional and Alternative Pain Treatment Market Shares, by Country, 2023
Figure 29: Latin American Conventional and Alternative Pain Treatment Market Shares, by Pain Management Type, 2023
Figure 30: Latin American Conventional and Alternative Pain Treatment Market Shares for Pharmaceuticals/Drug Therapy, by Type, 2023
Figure 31: Latin American Conventional and Alternative Pain Treatment Market Shares for Devices, by Type, 2023
Figure 32: Latin American Conventional and Alternative Pain Treatment Market Shares, by Application, 2023
Figure 33: Latin American Conventional and Alternative Pain Treatment Market Shares, by Country, 2023
Figure 34: Middle Eastern & African Conventional and Alternative Pain Treatment Market Shares, by Pain Management Type, 2023
Figure 35: Middle Eastern & African Conventional and Alternative Pain Treatment Market Shares for Pharmaceuticals/Drug Therapy, by Type, 2023
Figure 36: Middle Eastern & African Conventional and Alternative Pain Treatment Market Shares for Devices, by Type, 2023
Figure 37: Middle Eastern & African Conventional and Alternative Pain Treatment Market Shares, by Application, 2023
Figure 38: Middle Eastern & African Conventional and Alternative Pain Treatment Market Shares, by Sub-Region, 2023
Figure 39: Leading Players in the Conventional and Alternative Pain Treatment Market, 2023
Figure 40: Snapshot: Key ESG Trends in the Conventional and Alternative Pain Treatment Industry
Figure 41: Viewpoints on Sustainable Medical Devices
Figure 42: Abbott: Revenue Shares, by Business Unit, 2023
Figure 43: Abbott: Revenue Shares, by Country/Region, 2023
Figure 44: AbbVie Inc.: Revenue Shares, by Business Unit, 2023
Figure 45: AbbVie Inc.: Revenue Shares, by Country/Region, 2023
Figure 46: Amgen Inc.: Revenue Shares, by Business Unit, 2023
Figure 47: Amgen Inc.: Revenue Shares, by Country/Region, 2023
Figure 48: Baxter.: Revenue Shares, by Business Unit, 2023
Figure 49: Baxter: Revenue Shares, by Country/Region, 2023
Figure 50: Bayer AG: Revenue Shares, by Country/Region, 2023
Figure 51: Bayer AG: Revenue Shares, by Business Unit, 2023
Figure 52: Boehringer Ingelheim International GmbH: Revenue Shares, by Business Unit, 2023
Figure 53: Boehringer Ingelheim International GmbH: Revenue Shares, by Country/Region, 2023
Figure 54: Boston Scientific Corp.: Revenue Shares, by Business Unit, 2023
Figure 55: Boston Scientific Corp.: Revenue Shares, by Country/Region, 2023
Figure 56: GSK Plc: Revenue Shares, by Business Unit, 2023
Figure 57: GSK Plc: Revenue Shares, by Country/Region, 2023
Figure 58: Johnson and Johnson Services Inc.: Revenue Shares, by Business Unit, 2023
Figure 59: Johnson and Johnson Services Inc.: Revenue Shares, by Country/Region, 2023
Figure 60: Lilly: Revenue Shares, by Business Unit, 2023
Figure 61: Lilly: Revenue Shares, by Country/Region, 2023
Figure 62: Medtronic.: Revenue Shares, by Business Unit, 2023
Figure 63: Medtronic: Revenue Shares, by Country/Region, 2023
Figure 64: Merck & Co. Inc.: Revenue Shares, by Business Unit, 2023
Figure 65: Merck & Co. Inc.: Revenue Shares, by Country/Region, 2023
Figure 66: Novartis AG: Revenue Shares, by Business Unit, 2023
Figure 67: Novartis AG: Revenue Shares, by Country/Region, 2023
Figure 68: Pfizer Inc.: Revenue Shares, by Business Unit, 2023
Figure 69: Pfizer Inc.: Revenue Shares, by Country/Region, 2023
Figure 70: Teva Pharmaceutical Industries Ltd.: Revenue Shares, Business Unit, 2023
Figure 71: Teva Pharmaceutical Industries Ltd.: Revenue Shares, by Country/Region, 2023

Companies Mentioned

  • Abbott
  • AbbVie Inc.
  • Amgen Inc.
  • Baxter
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Boston Scientific Corp.
  • GSK PLC
  • Johnson & Johnson Services Inc.
  • Lilly
  • Medtronic
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages173
PublishedNovember 2024
Forecast Period2024 - 2029
Estimated Market Value ( USD ) in 2024 $ 96.2 Billion
Forecasted Market Value ( USD ) by 2029 $ 144.2 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Pain Management Global Market Report 2025 - Product Image

Pain Management Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Neuropathic Pain - Global Strategic Business Report - Product Image

Neuropathic Pain - Global Strategic Business Report

  • Report
  • 386 Pages
  • Global
From
Non-opioid Pain Treatment - Global Strategic Business Report - Product Image

Non-opioid Pain Treatment - Global Strategic Business Report

  • Report
  • 480 Pages
  • Global
From
Non-Opioid Pain Treatment Market Report 2025 - Product Image

Non-Opioid Pain Treatment Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Wrist Pain Treatment Market - Global Forecast 2025-2030 - Product Image

Wrist Pain Treatment Market - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.